Similar articles for PMID: 17669349

Year	Number of Results
1976	1
1997	1
2001	1
2002	1
2003	4
2004	8
2005	24
2006	28
2007	16
2008	16
2009	15
2010	10
2011	17
2012	17
2013	10
2014	6
2015	3
2016	1
2017	2
2018	1
2019	1
2020	1
2024	0

1

[Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].

Gonçalves A, Bertucci F, Birnbaum D, Borg JP. Gonçalves A, et al. Med Sci (Paris). 2007 Mar;23 Spec No 1:23-6. doi: 10.1051/medsci/2007231s23. Med Sci (Paris). 2007. PMID: 17669349 Free article. Review. French.

2

SELDI-TOF serum proteomics and breast cancer: which perspective?

Garrisi VM, Abbate I, Quaranta M, Mangia A, Tommasi S, Paradiso A. Garrisi VM, et al. Expert Rev Proteomics. 2008 Dec;5(6):779-85. doi: 10.1586/14789450.5.6.779. Expert Rev Proteomics. 2008. PMID: 19086858 Review.

3

A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.

Liu XP, Shen J, Li ZF, Yan L, Gu J. Liu XP, et al. Cancer Invest. 2006 Dec;24(8):747-53. doi: 10.1080/07357900601063873. Cancer Invest. 2006. PMID: 17162557

4

[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].

Solassol J, Marin P, Maudelonde T, Mangé A. Solassol J, et al. Bull Cancer. 2005 Sep;92(9):763-8. Bull Cancer. 2005. PMID: 16203265 Free article. Review. French.

5

Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.

Diamandis EP. Diamandis EP. Cancer Res. 2006 Jun 1;66(11):5540-1. doi: 10.1158/0008-5472.CAN-05-4503. Cancer Res. 2006. PMID: 16740686 No abstract available.

6

[Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].

Zhang GQ, Du J, Pang D. Zhang GQ, et al. Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):204-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16875606 Chinese.

7

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.

Engwegen JY, Gast MC, Schellens JH, Beijnen JH. Engwegen JY, et al. Trends Pharmacol Sci. 2006 May;27(5):251-9. doi: 10.1016/j.tips.2006.03.003. Epub 2006 Apr 4. Trends Pharmacol Sci. 2006. PMID: 16600386 Review.

8

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH. Gast MC, et al. Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Breast Cancer Res Treat. 2009. PMID: 19082706 Review.

9

Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.

Ricolleau G, Charbonnel C, Lodé L, Loussouarn D, Joalland MP, Bogumil R, Jourdain S, Minvielle S, Campone M, Déporte-Fety R, Campion L, Jézéquel P. Ricolleau G, et al. Proteomics. 2006 Mar;6(6):1963-75. doi: 10.1002/pmic.200500283. Proteomics. 2006. PMID: 16470659

10

[Clinical significance of serum proteomic patterns in diagnosis of breast cancer].

Liu DH, Zhang LM, Feng WY. Liu DH, et al. Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):770-1. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17366791 Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

166 results

Results by year